28 May 2025 – Sydney, Australia | ReNerve Limited has received marketing approval in Bahrain for its FDA-cleared NervAlign® Nerve Cuff™ product for peripheral nerve injuries (PNIs), marking its first regulatory milestone in the Middle East with its latest partner, Union MediScience B.S.C.
The approval will allow for the commercial rollout in Bahrain, and lays the foundation for expansion across the Gulf region.
The move follows ReNerve’s exclusive distribution agreement with Union MediScience, which covers five key markets: Bahrain, Saudi Arabia, Kuwait, the United Arab Emirates, and Qatar.
Highlights:
-
First marketing approval secured in the Middle East via regional partner Union MediScience B.S.C.
-
Bahrain launch aims to support a broader Gulf expansion in the region.
-
Middle East and North Africa (MENA) market valued at over USD $80 million and growing at 35% annually .
-
Part of a global nerve repair market projected to grow from USD $1.96 billion in 2024 to USD $6.19 billion by 2031 .
Commenting on the approval, ReNerve Director, Dr Julian Chick, stated: “The ReNerve team has done a great job on the approvals, and working with the wonderful people at Union MediScience has been excellent. We look forward to the commercialisation in Bahrain and further expanding our sales and marketing efforts in the region."
The NervAlign® Nerve Cuff™
he NervAlign® Nerve Cuff™ is a bioabsorbable wrap designed to protect and guide nerve regeneration, with demonstrated clinical outcomes including significant reductions in post-surgical pain. The product is already approved and used in the United States, and is part of a broader pipeline of nerve repair solutions under development by ReNerve.
For further information, please contact:
Dr Julian Chick
CEO & Managing Director
[email protected]
Jane Morgan
Jane Morgan Management
Investor & Media Relations
[email protected]
About us:
About ReNerve Limited (ASX:RNV)
ReNerve Limited is transforming nerve repair and improving lives through breakthrough medical technology. Founded by a neurosurgeon and medtech researchers, ReNerve is a rapidly growing medical device company that has revolutionised peripheral nerve surgery with its innovative, ready-to-use solutionsfor peripheral nerve injuries (PNI). Our scientifically-backed products are delivering measurably better outcomes for patients worldwide.
Contact details:
Jane Morgan
Jane Morgan Management
Investor & Media Relations
[email protected]
